Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05731778Phase 4Completed
Phase 4, randomised, double-blind trial of stannous fluoride in gingivitis (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Bleeding Index (BOP) at 9 weeks and Oral Inflammatory Load at 9 weeks. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05731778.